Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2009

Primary Completion Date

December 16, 2009

Study Completion Date

December 16, 2009

Conditions

Neoplasm

Interventions

DRUG

F-18 (BAY85-8050)

Cancer patients, injection of BAY 85-8050, PET/CT

DRUG

F-18 (BAY85-8050)

Healthy volunteers, injection of BAY 85-8050, whole body PET/CT for determination of effective dose, kinetics of BAY 85-8050 in blood

Trial Locations (1)

München